Insiders · Profile

Sukhtian Ghiath M.

Director at Outlook Therapeutics. Filing since 2 Feb 2021. CIK 0001717441

Company

Date

Role

Action

Shares

Amount

Of holding

OTLK Outlook Therapeutics, Inc.

12 Aug 2026

Director

Bought

2,525,252

$2.50M

11.4%

OTLK Outlook Therapeutics, Inc.

28 May 2026

Director

Bought

8,539,709

$5.00M

63.0%

OTLK Outlook Therapeutics, Inc.

29 Nov 2021

Director

Bought

16,000,000

$20.00M

135%

OTLK Outlook Therapeutics, Inc.

2 Feb 2021

Director

Bought

8,360,000

$8.36M

340%

4 decisions on file.